US equities
|
SPCX
$168.21
▲+5.82%
NVDA
$237.21
▲+1.39%
MU
$1,064.63
▼-0.95%
TSLA
$378.19
▲+2.05%
MSFT
$526.11
▲+1.66%
INTC
$116.89
▼-2.04%
SNDK
$1,720.68
▲+0.04%
META
$745.20
▲+2.35%
SPCX
$168.21
▲+5.82%
NVDA
$237.21
▲+1.39%
MU
$1,064.63
▼-0.95%
TSLA
$378.19
▲+2.05%
MSFT
$526.11
▲+1.66%
INTC
$116.89
▼-2.04%
SNDK
$1,720.68
▲+0.04%
META
$745.20
▲+2.35%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Microbot Medical Inc. - Common Stock
(NQ:
MBOT
)
1.130
-0.030 (-2.59%)
Delayed Quote
Updated: 11:05 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Microbot Medical Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 22, 2023
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 22, 2023
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.
Via
Benzinga
Microbot Medical Stock Shoots Higher: Here's Why
↗
May 22, 2023
Microbot Medical Inc (NASDAQ: MBOT) announced an extended joint preclinical animal study at a
Via
Benzinga
Microbot Medical Inc. (NASDAQ: MBOT) Near the Top of Equities by Percentage Gain on 5/22
May 22, 2023
Via
Investor Brand Network
Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher
↗
May 22, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded down 0.20% to 33,359.71 while the NASDAQ rose 0.47% to 12,717.37. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 22, 2023
Via
Benzinga
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
May 22, 2023
A team of six leading European interventional radiologists used the LIBERTY® Surgical Robotic System and performed a total of 48 catheterizations
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases
May 18, 2023
Company will enable focus on its LIBERTY technology through the introduction of the Core Business Focus Program coupled with cost restructuring to support it
From
Microbot Medical Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 18, 2023
Via
Benzinga
Zscaler To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
↗
May 09, 2023
Stifel raised the price target for XPO, Inc. (NYSE: XPO) from $48 to $51. Stifel analyst J. Bruce Chan downgraded the stock from Buy to Hold. XPO shares fell 1.5% to $47.72 in pre-market trading.
Via
Benzinga
Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System
May 08, 2023
Distinguished publisher and lecturer, Interventional Radiologist Prof. Francisco Cesar Carnevale Expected to Perform the World’s First Clinical Cases at the Prestigious Institute of Radiology at the...
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces Final Data From Its Recent Animal Study
May 05, 2023
Data supports next regulatory steps for the LIBERTY Robotic System
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization
May 03, 2023
95% success rate of reaching pre-determined vascular target with no intraoperative complications presented during pre-clinical studies
From
Microbot Medical Inc.
Via
GlobeNewswire
Gerry O’Sullivan, the Latest Member to Join Microbot Medical’s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases
March 23, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
↗
April 14, 2023
On Friday, 127 companies set new 52-week lows.
Via
Benzinga
Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to
March 16, 2023
Internationally Recognized Academic Leader Awarded the National Institute for Health Research (NIHR) Research Rising Star Award, and Cardiovascular and Interventional Radiology (CVIR) Editors Medal
From
Microbot Medical Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board
March 13, 2023
Internationally Recognized and Awarded Interventional Radiologist Enhances Depth of Expertise as the LIBERTY® Robotic System Races Towards Regularity and Commercialization Objectives
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical’s Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY® Robotic System During Podium Presentation at Prestigious Robotics Conference
March 09, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System
March 02, 2023
Engagement with Interventional Radiologists Reaches Highest Level Yet as Company Continues to Progress Through Regulatory and Clinical Phases; Company Seeking to Create Interest and Anticipation for...
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting
February 28, 2023
Continues to Raise Awareness of the LIBERTY® Robotic System Ahead of Commercialization Plans
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Expands its Geographic Presence to South America with the Addition of Francisco C. Carnevale, MD, PhD, FSIR to its Scientific Advisory Board
February 27, 2023
Increases Key Opinion Leaders to 13 Throughout the Americas, Israel, and Europe to Support the Company’s Next Regulatory and Commercialization Paths for the LIBERTY® Robotic System
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical’s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan
February 23, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series
January 31, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next ‘Access-Ability Live by MBOT’ Webinar
January 06, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series
December 14, 2022
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel
December 08, 2022
Pace of Jurisdictional Allowances Parallels Pre-Clinical and Regulatory Progress
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance
November 18, 2022
Advanced Features of Remote Controller Specifically Developed to Deliver an Enhanced User Experience During Endovascular Procedures
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space
November 15, 2022
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System
November 03, 2022
Corresponding Application Previously Granted in the U.S. as the Company Continues to Create Global Barriers to Entry for its Novel Technology
From
Microbot Medical Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
